Mohan Bala

2023

In 2023, Mohan Bala earned a total compensation of $1.6M as Senior Vice President, Chief Development Officer at Mersana Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$111,930
Option Awards$762,804
Salary$430,500
Stock Awards$269,100
Other$7,000
Total$1,581,334

Bala received $762.8K in option awards, accounting for 48% of the total pay in 2023.

Bala also received $111.9K in non-equity incentive plan, $430.5K in salary, $269.1K in stock awards and $7K in other compensation.

Rankings

In 2023, Mohan Bala's compensation ranked 749th out of 2,978 executives tracked by ExecPay. In other words, Bala earned more than 74.8% of executives.

ClassificationRankingPercentile
All
749
out of 2,978
75th
Division
Manufacturing
429
out of 1,637
74th
Major group
Chemicals And Allied Products
291
out of 906
68th
Industry group
Drugs
285
out of 869
67th
Industry
Pharmaceutical Preparations
188
out of 627
70th
Source: SEC filing on April 26, 2024.

Bala's colleagues

We found six more compensation records of executives who worked with Mohan Bala at Mersana Therapeutics in 2023.

2023

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2023

Martin Huber

Mersana Therapeutics

Chief Executive Officer

2023

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

2023

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2023

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2023

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

News

You may also like